Logo
S

Sosei Heptares

162 employees

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Molecular Pharmacology
Chemistry
Neurology
Pre-Clinical
Structure-Based Drug Design platform capabilities
Drug Discovery
Computational Chemistry
Development
Therapeutics
Immunology
Inflammatory
GPCR
Gastroenterology
Novel Medicines

Date founded

1990

Funding rounds raised

Total raised

$30M

from 7 investors over 7 rounds

S

Sosei Heptares raised $5M on May 18, 2017

Investors: Teva UK Limited

S

Sosei Heptares raised $21M on June 27, 2013

Investors: Takeda UK Limited, The Stanley Foundation and Clarus Ventures, LLC

S

Sosei Heptares raised $30M on February 24, 2009

Investors: MVM Partners and Clarus Ventures, LLC

S

Sosei Heptares raised undisclosed on August 10, 2007

Investors: MVM Partners

FAQ